Aytu Biopharma Inc expected to post a loss of 41  cents a share - Earnings Preview

Aytu Biopharma

13/05/2022 21:07

* Aytu Biopharma Inc  AYTU.OQ   AYTU.O  is expected to show
a rise
in quarterly revenue when it reports  results on May 16
(estimated). 
    * The Englewood Colorado-based  company is expected to
report  a
83.9% increase in revenue to $24.8 million from $13.48 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Aytu Biopharma Inc
is for
a loss of 41 cents per share. For the same quarter last year,
the company reported a loss of $1.41 per share.
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aytu
Biopharma
Inc is $11​, above​ its last closing price of $0.47. ​​​

This summary was machine generated May 13 at 20:07 GMT.  All
figures in US dollars  unless otherwise stated